Director of Medical Excellence and Innovation
Apply NowCompany: Melinta Therapeutics
Location: Parsippany, NJ 07054
Description:
DIRECTOR OF MEDICAL EXCELLENCE AND INNOVATION
Melinta Therapeutics is a biopharmaceutical company with strong commercial and medical capabilities dedicated to providing innovative therapies to people impacted by acute and life-threatening illnesses. Melinta's current portfolio includes seven commercial stage products and one investigational product under review by FDA: BAXDELA (delafloxacin), KIMYRSA (oritavancin), MINOCIN (minocycline) for Injection, ORBACTIV (oritavancin), REZZAYO (rezafungin for injection), TOPROL-XL (metoprolol succinate), VABOMERE (meropenem and vaborbactam), and cefepime-taniborbactam. With an unsurpassed commitment to providers and patients, Melinta is dedicated to saving lives threatened by the global public health crisis of infections. We are small but mighty, with an unsurpassed commitment to patients, one another, and the business. We strive to offer a dynamic work environment, in which innovation, teamwork, knowledge and flexibility are valued.
Melinta's portfolio has the unique ability to offer providers and patients a range of solutions that can meet the tremendous need for treating serious infections. Visit www.melinta.com for more information.
Melinta Therapeutics is a biopharmaceutical company with strong commercial and medical capabilities dedicated to providing innovative therapies to people impacted by acute and life-threatening illnesses. Melinta's current portfolio includes seven commercial stage products and one investigational product under review by FDA: BAXDELA (delafloxacin), KIMYRSA (oritavancin), MINOCIN (minocycline) for Injection, ORBACTIV (oritavancin), REZZAYO (rezafungin for injection), TOPROL-XL (metoprolol succinate), VABOMERE (meropenem and vaborbactam), and cefepime-taniborbactam. With an unsurpassed commitment to providers and patients, Melinta is dedicated to saving lives threatened by the global public health crisis of infections. We are small but mighty, with an unsurpassed commitment to patients, one another, and the business. We strive to offer a dynamic work environment, in which innovation, teamwork, knowledge and flexibility are valued.
Melinta's portfolio has the unique ability to offer providers and patients a range of solutions that can meet the tremendous need for treating serious infections. Visit www.melinta.com for more information.
Position Summary
The Director of Medical Excellence and Innovation will lead transformative initiatives to modernize medical affairs through the adoption of advanced technologies, digital solutions, and AI-based applications. This role is instrumental in driving operational efficiency, fostering innovation, and enhancing the strategic impact of medical affairs. The ideal candidate will possess deep expertise in digital transformation, a visionary mindset, and the ability to bridge technology and medical operations to deliver cutting-edge solutions.
Key Responsibilities
Strategic Leadership in Digital Transformation:
Advancing Technology-Driven Excellence:
Innovation in Medical Affairs:
Project-based external KOL/DOL engagement, insight gathering and partnerships:
Cross-Functional and Global Collaboration:
Qualifications
Travel
Up to 25% domestic and international travel for conferences, technology assessments, and strategic initiatives
Position Type
Full Time; will consider flexible work arrangements
Melinta Therapeutics appreciates your interest in our company as a place of employment. It is our Company's policy to employ, retain, promote, terminate and otherwise treat all employees and job applicants without regard to any individuals' age, ancestry, color, gender, gender identity or expression, genetic information, marital status, medical condition, mental or physical disability, national origin, protected family care or medical leave status, race, sexual orientation, military or veteran status, or any other characteristic protected by federal, state, or local laws.
Melinta Therapeutics is a biopharmaceutical company with strong commercial and medical capabilities dedicated to providing innovative therapies to people impacted by acute and life-threatening illnesses. Melinta's current portfolio includes seven commercial stage products and one investigational product under review by FDA: BAXDELA (delafloxacin), KIMYRSA (oritavancin), MINOCIN (minocycline) for Injection, ORBACTIV (oritavancin), REZZAYO (rezafungin for injection), TOPROL-XL (metoprolol succinate), VABOMERE (meropenem and vaborbactam), and cefepime-taniborbactam. With an unsurpassed commitment to providers and patients, Melinta is dedicated to saving lives threatened by the global public health crisis of infections. We are small but mighty, with an unsurpassed commitment to patients, one another, and the business. We strive to offer a dynamic work environment, in which innovation, teamwork, knowledge and flexibility are valued.
Melinta's portfolio has the unique ability to offer providers and patients a range of solutions that can meet the tremendous need for treating serious infections. Visit www.melinta.com for more information.
Melinta Therapeutics is a biopharmaceutical company with strong commercial and medical capabilities dedicated to providing innovative therapies to people impacted by acute and life-threatening illnesses. Melinta's current portfolio includes seven commercial stage products and one investigational product under review by FDA: BAXDELA (delafloxacin), KIMYRSA (oritavancin), MINOCIN (minocycline) for Injection, ORBACTIV (oritavancin), REZZAYO (rezafungin for injection), TOPROL-XL (metoprolol succinate), VABOMERE (meropenem and vaborbactam), and cefepime-taniborbactam. With an unsurpassed commitment to providers and patients, Melinta is dedicated to saving lives threatened by the global public health crisis of infections. We are small but mighty, with an unsurpassed commitment to patients, one another, and the business. We strive to offer a dynamic work environment, in which innovation, teamwork, knowledge and flexibility are valued.
Melinta's portfolio has the unique ability to offer providers and patients a range of solutions that can meet the tremendous need for treating serious infections. Visit www.melinta.com for more information.
Position Summary
The Director of Medical Excellence and Innovation will lead transformative initiatives to modernize medical affairs through the adoption of advanced technologies, digital solutions, and AI-based applications. This role is instrumental in driving operational efficiency, fostering innovation, and enhancing the strategic impact of medical affairs. The ideal candidate will possess deep expertise in digital transformation, a visionary mindset, and the ability to bridge technology and medical operations to deliver cutting-edge solutions.
Key Responsibilities
Strategic Leadership in Digital Transformation:
- Develop and implement a forward-thinking strategy that leverages technology and AI to revolutionize medical affairs processes and outcomes.
- Champion the adoption of digital tools and platforms to elevate the efficiency, scalability, and precision of medical operations.
- Collaborate with executive leadership to align digital innovation with the broader organizational vision and objectives.
- Foster a culture of digital curiosity, innovation, and continuous learning within the medical affairs organization.
- Mentor team members and stakeholders in digital skills and transformational thinking.
Advancing Technology-Driven Excellence:
- Lead the evaluation, selection, and implementation of digital solutions, including AI-based applications for content creation, medical inquiry management, and real-time insights generation
- Oversee the integration of advanced data analytics and visualization tools to enhance decision-making and strategic planning
- Drive the deployment of natural language processing (NLP), machine learning, and predictive analytics to optimize medical information services and stakeholder engagement
Innovation in Medical Affairs:
- Identify and adopt emerging technologies, such as generartive AI, to transform medical education, engagement, and operations
- Partner with external innovators, startups, and technology providers to bring new capabilities into the medical affairs ecosystem
- Establish a robust framework for piloting and scaling innovative initiatives, ensuring measurable outcomes and value generation
Project-based external KOL/DOL engagement, insight gathering and partnerships:
- Lead country-wide initiatives and pilots in partnership with internal and external stakeholders to experiment and implement digital/tech tools/services
Cross-Functional and Global Collaboration:
- Collaborate with medical, commercial, regulatory, and clinical development teams to integrate digital solutions seamlessly across functions
- Join/lead a company-wide cross-functional network of digital champions to drive innovation and share best practices across regions
- Act as the primary point of contact for external technology partners and ensure alignment with organizational goals
Qualifications
- Advanced degree in a relevant field (e.g., PharmD, MD, PhD, MBA, or MSc with a focus on digital health or technology innovation) preferred.
- Minimum of 3 years of experience in medical affairs
- Proven track record of contributing and/or leading technology-driven initiatives in a healthcare or pharma
- Expertise in AI-based applications, digital platforms, and emerging technologies for medical affairs
- Understanding of data analytics, machine learning, and their applications in medical operations
- Exceptional project management, strategic thinking, and problem-solving skills
- Outstanding communication skills, with the ability to convey complex technical concepts to diverse audiences
Travel
Up to 25% domestic and international travel for conferences, technology assessments, and strategic initiatives
Position Type
Full Time; will consider flexible work arrangements
Melinta Therapeutics appreciates your interest in our company as a place of employment. It is our Company's policy to employ, retain, promote, terminate and otherwise treat all employees and job applicants without regard to any individuals' age, ancestry, color, gender, gender identity or expression, genetic information, marital status, medical condition, mental or physical disability, national origin, protected family care or medical leave status, race, sexual orientation, military or veteran status, or any other characteristic protected by federal, state, or local laws.